LÖSLICHKEITSOPTIMIERUNG VON IMMUNBINDERN

Patent europeic · EP3241843 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3241843
Numer da la dumonda
EP17161990
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
25-06-2009
Publitgà
08-11-2017
Concedì
28-07-2021
La protecziun finescha il pli tard
24-06-2029
Proxima taxa annuala scadenta
30-06-2027
Classas IPC
C07K 16/22 (2006.01)
C07K 16/24 (2006.01)
Prioritad
US 75692 P 25.06.2008
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-07-2026

    Next annual fee due on

    Next annual fee due on
    30.06.2026 → 30.06.2027

    Published in Swissreg on 01.07.2026

  2. 01-07-2025

    Next annual fee due on

    Next annual fee due on
    30.06.2025 → 30.06.2026

    Published in Swissreg on 01.07.2025

  3. 01-07-2024

    Midada

    Published in Swissreg on 01.07.2024

  4. 01-07-2023

    Midada

    Published in Swissreg on 01.07.2023

  5. 01-07-2022

    Midada

    Published in Swissreg on 01.07.2022

  6. 08-06-2022

    Midada

    Published in Swissreg on 08.06.2022

  7. 14-09-2021

    Represchentant inscrit

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3013 Bern

    Published in Swissreg on 14.09.2021

  8. 28-07-2021

    Concedì

    Published in Swissreg on 28.07.2021

Partidas

Possessur

Novartis AG

Lichtstrasse 35, 4056 Basel

Represchentant

Bovard AG

BOVARD AG Patent- und Markenanwälte

Optingenstrasse 16, 3013 Bern

Inventur

BORRAS, Leonardo

4056 Basel

URECH, David

4056 Basel

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.